. Brooks D.J., Sagar H. and the UK-Irish Entacapone Study Group;

2003

February

J Neurol Neurosurg Psychiatry

Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson¿s disease: a randomised, placebo controlled, double blind, six month study

Published

0